The anticonvulsant activities of N-benzyl 3-methoxypropionamides

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 11, 1999, Pages 2381-2389

  Andurkar, Shridhar V ^a   Stables, James P ^b   Kohn, Harold ^a  

^a University of Houston   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Amino acids and derivatives; Anticonvulsants; Peptoids; Substituents effects

Indexed keywords

ANTICONVULSIVE AGENT; N BENZYL 2,3 DIMETHOXYPROPIONAMIDE; N BENZYL 3 METHOXYPROPIONAMIDE; PHENOBARBITAL; PROPIONAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ACETAMIDES; AMIDES; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; MICE; PENTYLENETETRAZOLE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

ANIMALIA;

EID: 0033492029     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00186-8     Document Type: Article

References (23)

1. Choi D., Stables J.P., Kohn H. Bioorg. Med. Chem. 4:1996;2105.
2. Porter R.J., Cereghino J.J., Gladding G.D., Hessie B.J., Kupferberg H.J., Scoville B., White B.G. Cleveland Clin. Q. 51:1984;293.
3. Conley J.D., Kohn H. J. Med. Chem. 30:1987;567.
4. Kohn H., Conley J.D. Chem. Brit. 24:1988;231.
5. Choi D., Stables J.P., Kohn H. J. Med. Chem. 39:1996;1907.
6. Kohn H., Sawhney K.N., LeGall P., Robertson D.W., Leander J.D. J. Med. Chem. 34:1991;2444.
7. Kohn H., Conley J.D., Leander J.D. Brain Res. 457:1988;371.
8. Kohn H., Sawhney K.N., Bardel P., Robertson D.W., Leander J.D. J. Med. Chem. 36:1993;3350.
9. Gluchowski C., Bischoff T.E., Garst M.E., Kaplan L.J., Dietrich S.W., Aswad A.S., Gaffney M.A., Aoki K.R., Garcia C., Wheeler L.A. J. Med. Chem. 34:1991;392.
10. Tanaka A., Yamashita K. Agric. Biol. Chem. 44:1980;199.
11. For comparable procedures for resolving stereoisomers, see: Weisman, G. R. In Asymmetric Synthesis-Analytical Methods, Morrison, J. D., Ed.; Academic: New York, 1983; Vol. 1, pp 153-171.
12. For comparable procedures resolving stereoisomers, see: Dyllick-Brenzinger, R.; Roberts, J. D. J. Am. Chem. Soc. 1980, 102, 1166.
13. For comparable procedures resolving stereoisomers, see: Parker, D.; Taylor, R. J. Tetrahedron 1987, 43, 5431.
14. Stables, J. P.; Kupferberg, H. J. In Molecular and Cellular Targets for Antiepileptic Drugs, Avanzini, G.; Tanganelli, P.; Avoli, M., Eds.; John Libbey: London, 1997, pp 191-198.
15. Swinyard, E. A.; Woodhead, J. H.; White, M. S.; Franklin, M. R. In Antiepileptic Drugs, 3rd ed., Levy, R. H.; Dreifuss, F. E.; Mattson, R. H.; Meldrum, B. S.; Penry, J. K., Eds.; Raven Press: New York, 1989, p 97.
16. Dunham N.W., Miwa T.S. J. Am. Pharm. Assoc. 46:1957;208.
17. White, H. S.; Woodhead, J. H.; Franklin, M. R. In Antiepileptic Drugs, 4th ed., Levy, R. H.; Mattson, R. H.; Meldrum, B. S., Eds.; Raven Press: New York, 1995, pp 99-110.
18. Andurkar S.V., Stables J.P., Kohn H. Tetrahedron: Asymmetry. 9:1998;3841.
19. Attempted separation of the diastereomers using other blends of TLC solvents (e.g. ethyl acetate-petroleum ether, ethyl acetate-hexanes, ethyl acetate-acetone, chloroform-methanol) were unsuccessful.
20. Swinyard E.A., Woodhead J.H., White H.S., Franklin M.R. General Principles. Experimental Selection, Quantification, and Evaluation of Anticonvulsants. Levy R.H., Driefuss F.E., Mattson R.H., Meldrum B.S., Penry J.K. Antiepileptic Drugs, 3rd edn. 1989;85-102 Raven Press, New York.
21. Woodbury L.A., Davenport V.D. Arch. Int. Pharamacodyn. Ther. 92:1952;97-104.
22. White, H. S.; Woodhead, J. H.; Franklin, M. R. In Antiepileptic Drugs, Levy, R. H.; Mattson, R. H.; Meldrum, B. S. Eds.; Raven: New York, 1998, pp 99-100.
23. Finney, D. J. Probit Analysis, 3rd ed. Cambridge University Press: London, 1971.